Product Images Veletri
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Veletri NDC 66215-402 by Actelion Pharmaceuticals Us, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - veletri 01
Principal Display Panel - 0.5 mg Vial Carton - veletri 02
This is a medication called VELETRI, with the active ingredient epoprostenol, which is used for intravenous infusion only. Each vial contains 0.5mg of epoprostenol, 50mg of arginine, and 100mg of sucrose. The medication must be stored between 20°C to 25°C and should be kept in the carton and away from direct sunlight. The unused portion of the single-dose vial should be discarded. For more information on dosage and storage stability of solutions, please see the full prescribing information. The medication is manufactured in the Czech Republic for Actelion Pharmaceuticals US, Inc. and the NDC number is 66215-401-01.*
Principal Display Panel - 1.5 mg Vial Carton - veletri 03
This is a product information sheet for Veletri, a medication used in the treatment of pulmonary arterial hypertension. It is manufactured in the Czech Republic and distributed by Actelon Pharmaceuticals in the US. Each vial contains 1.5mg of epoprostenol sodium, with additional ingredients such as arginine and sucrose. The medication should be stored at controlled room temperature and protected from direct sunlight. The full prescribing information should be consulted for dilution instructions and storage of solutions. The expiration date is also listed.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.